BioPhorum’s HVAC Optimization Tool - Reducing the environmental impact of cleanrooms
Date
15 April 2026
Time
10:00-11:00 EST | 15:00-16:00 GMT | 16:00-17:00 CET
Key features
HVAC systems are one of the largest drivers of energy use and emissions in GMP manufacturing—but they also represent a major, often untapped, optimisation opportunity. In this webinar, you’ll learn why HVAC has been prioritised and explore its environmental impact, including rising emissions, increasing green energy costs, and growing demand pressures.
You’ll get a practical walkthrough of the BioPhorum HVAC Optimization Assessment Tool—how it’s structured, how it’s used, and how it supports teams in identifying low‑CAPEX, low‑risk optimisation opportunities that can be applied to existing GMP facilities.
The session will show you how to prioritise actions using energy, carbon, cost, and risk lenses, helping you focus effort where it delivers the greatest value with minimal disruption. You’ll also see real‑world application pathways, including key validation and QA considerations, so you understand what implementation looks like in practice.
Finally, you’ll hear what comes next—from implementation planning and data requirements to future enhancements of the tool—and get an update on what else is happening within the HVAC team and across the wider BioPhorum community.
Why attend?
- Launching BioPhorum's HVAC Optimization Tool, information about what it is and where they can download
- What is the current environmental impact of clean rooms in the industry and why it is a problem
- Learn from HVAC and sustainability experts from biomanufacturers, suppliers, consultants and technology suppliers, on the latest advice on HVAC optmization, maintenance and technology
- Having a pratical and easy to use tool to support directly support implementation
- Opportuntities will reduce on site energy consumption, which will contribute to a reduction in scope 1 and 2 emssions or reduce the cost of green energy
Webinar registration
Our featured speakers
Laarari Loirdi
UCB
David Le Fort
UCB
Ade Ige
AstraZeneca
Gerry Williams
CRB Group
Towani Mtonga
Watson-Marlow Fluid Technology Solutions